Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
Clinical trial NCT03325010 · COMPLETED
Trial details
- NCT number
- NCT03325010
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-05
- Primary completion
- 2018-11-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.